REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH)

Q: What does CUSIP 76152G100 represent in this 13F holders report?

CUSIP 76152G100 is the security identifier for RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

Q: How many institutions held RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share in Q2 2023?

22 institutional investors reported RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 76152G100

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 13,730,837
Total 13F shares: 2,636,201
Share change: +1,384,454
Total reported value: $15,447,187
Put/Call ratio: 27%
Price per share: $5.86
Number of holders: 22
Value change: +$8,416,328
Number of buys: 18
Number of sells: 6

Security key

76152G100

Report period

Q2 2023

Institutions

Top holders

RVPH full security history Newer quarter: Q3 2023 Previous quarter: Q1 2023 REVIVA PHARMACEUTICALS HOLDINGS, INC. SEC filings REVIVA PHARMACEUTICALS HOLDINGS, INC. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 76152G100

Newer quarter: Q3 2023 Previous quarter: Q1 2023

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RVPH - REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
VANGUARD GROUP INC	13F	Company	4.2%	573,770	$2,404,096	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.1%	145,430	$609,351	—	31 Mar 2023	13F
EMC Capital Management	13F	Company	0.9%	123,915	$517,000	—	31 Mar 2023	13F
COLONY GROUP LLC	13F	Company	0.68%	93,000	$390,000	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	0.62%	84,954	$355,957	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.53%	73,108	$306,323	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.39%	53,200	$222,908	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	0.32%	44,400	$186,036	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.28%	38,435	$161,000	—	31 Mar 2023	13F
SABBY MANAGEMENT, LLC	13F	Company	0.21%	28,610	$119,876	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.2%	27,115	$113,612	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.14%	19,124	$80,000	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.12%	16,400	$68,716	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.11%	15,047	$63,047	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.09%	12,236	$51,269	—	31 Mar 2023	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0.07%	9,299	$38,963	—	31 Mar 2023	13F
Belvedere Trading LLC	13F	Company	0.05%	6,359	$26,644	—	31 Mar 2023	13F
WOLVERINE ASSET MANAGEMENT LLC	13F	Company	0.04%	6,104	$25,575	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.03%	3,526	$14,774	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.01%	1,519	$6,000	—	31 Mar 2023	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	110	$461	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	1	$4	—	31 Mar 2023	13F
VEDANTA PARTNERS, LLC	3/4/5	10%+ Owner	— mixed-class rows	1,127,207 mixed-class rows	—	—	08 Sep 2022	3/4/5

Institutional Holders of REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) as of Q2 2023

As of 30 Jun 2023, REVIVA PHARMACEUTICALS HOLDINGS, INC. - Common Stock, $0.0001 par value per share (RVPH) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,636,201 shares. The largest 10 holders included ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, COLONY GROUP LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., CITADEL ADVISORS LLC, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and SIMPLEX TRADING, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

Q2 2023 holders

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.